Allergan has agreed to pay $750 million to settle lawsuits in the US brought by direct purchasers of its Namenda Alzheimer’s drug in the US.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,